CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023		4,511,199
Beginning balance at Dec. 31, 2023	$ 79,105	$ 5	$ 470,521	$ (409,073)	$ 17,652
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for Employee Stock Purchase Plan (in shares)		746
Common stock issued for Employee Stock Purchase Plan	19		19
Common stock issuance (in shares)		444,444
Common stock issuance	1,541		1,541
Debt conversion to common stock (in shares)		11,824
Debt conversion to common stock	321		321
Stock-based compensation	49		49
Vesting of Restricted Stock Units (in shares)		1,298
Reverse stock split adjustment (in shares)		2,426
Distributions	(481)				(481)
Net income (loss)	(542)			(364)	(178)
End balance (in shares) at Mar. 31, 2024		4,971,937
Ending balance at Mar. 31, 2024	80,012	$ 5	472,451	(409,437)	16,993
Beginning balance (in shares) at Dec. 31, 2023		4,511,199
Beginning balance at Dec. 31, 2023	79,105	$ 5	470,521	(409,073)	17,652
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock received in sale of business	30
Net income (loss)	(4,698)
End balance (in shares) at Sep. 30, 2024		5,215,709
Ending balance at Sep. 30, 2024	79,778	$ 5	479,025	(418,589)	19,337
Beginning balance (in shares) at Mar. 31, 2024		4,971,937
Beginning balance at Mar. 31, 2024	80,012	$ 5	472,451	(409,437)	16,993
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for Employee Stock Purchase Plan (in shares)		2,061
Common stock issued for Employee Stock Purchase Plan	14		14
Stock-based compensation	(61)		(61)
Common stock received in sale of business (in shares)		(5,060)
Common stock received in sale of business	(30)		(30)
Common stock issued for acquisition (in shares)		17,640
Common stock issued for acquisition	156		156
Reverse stock split adjustment (in shares)		690
Contributions	301				301
Distributions	(1,380)				(1,380)
Net income (loss)	3,010			(364)	3,374
End balance (in shares) at Jun. 30, 2024		4,987,268
Ending balance at Jun. 30, 2024	82,022	$ 5	472,530	(409,801)	19,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for Employee Stock Purchase Plan (in shares)		4,300
Common stock issued for Employee Stock Purchase Plan	25		25
Stock-based compensation (in shares)		27,035
Stock-based compensation	1,964		1,964
Warrant exercises (in shares)		150,000
Warrant exercises	3,820		3,820
Common stock issued for acquisition (in shares)		47,106
Common stock issued for acquisition	250		250
Contributions	660		436		224
Distributions	(1,798)				(1,798)
Net income (loss)	(7,165)			(8,788)	1,623
End balance (in shares) at Sep. 30, 2024		5,215,709
Ending balance at Sep. 30, 2024	79,778	$ 5	479,025	(418,589)	19,337
Beginning balance (in shares) at Dec. 31, 2024		5,511,452
Beginning balance at Dec. 31, 2024	188,533	$ 6	489,409	(356,976)	56,094
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for Employee Stock Purchase Plan (in shares)		1,161
Common stock issued for Employee Stock Purchase Plan	40		40
Stock-based compensation (in shares)		422,091
Stock-based compensation	23,252		23,252
Vesting of Restricted Stock Units (in shares)		15,835
Distributions	(7,364)				(7,364)
Net income (loss)	50,806			21,217	29,589
End balance (in shares) at Mar. 31, 2025		5,950,539
Ending balance at Mar. 31, 2025	255,267	$ 6	512,701	(335,759)	78,319
Beginning balance (in shares) at Dec. 31, 2024		5,511,452
Beginning balance at Dec. 31, 2024	188,533	$ 6	489,409	(356,976)	56,094
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock received in sale of business	0
Net income (loss)	163,749
End balance (in shares) at Sep. 30, 2025		6,905,262
Ending balance at Sep. 30, 2025	438,033	$ 7	615,180	(298,021)	120,867
Beginning balance (in shares) at Mar. 31, 2025		5,950,539
Beginning balance at Mar. 31, 2025	255,267	$ 6	512,701	(335,759)	78,319
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for Employee Stock Purchase Plan (in shares)		866
Common stock issued for Employee Stock Purchase Plan	65		65
Debt conversion to common stock (in shares)		17,874
Debt conversion to common stock	477		477
Stock-based compensation (in shares)		602,798
Stock-based compensation	75,305	$ 1	75,304
Vesting of Restricted Stock Units (in shares)		23,032
Asset acquisition noncontrolling interest	789				789
Contributions	242		152		90
Distributions	(11,412)				(11,412)
Net income (loss)	16,144			(17,697)	33,841
End balance (in shares) at Jun. 30, 2025		6,595,109
Ending balance at Jun. 30, 2025	336,877	$ 7	588,699	(353,456)	101,627
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for Employee Stock Purchase Plan (in shares)		351
Common stock issued for Employee Stock Purchase Plan	42		42
Stock-based compensation (in shares)		307,700
Stock-based compensation	26,189		26,189
Common stock issued for acquisition (in shares)		2,102
Common stock issued for acquisition	250		250
Asset acquisition noncontrolling interest	1,200				1,200
Contributions	74				74
Distributions	(23,398)				(23,398)
Net income (loss)	96,799			55,435	41,364
End balance (in shares) at Sep. 30, 2025		6,905,262
Ending balance at Sep. 30, 2025	$ 438,033	$ 7	$ 615,180	$ (298,021)	$ 120,867